Beneficial Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Asthma: A Literature Review

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are approved to treat type 2 diabetes mellitus. The anti-inflammatory and anti-obesity properties of GLP-1 RAs as well as their moderating effects on multiple pathobiological pathways in asthma pathogenesis may decrease asthma exacerbations, impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanwar, Meeta K, Sunku, Ramya, Alruwaili, Faisal, Mufti, Mariam A, Raji, Mukaila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705051/
https://www.ncbi.nlm.nih.gov/pubmed/36457601
http://dx.doi.org/10.7759/cureus.30812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705051/
https://www.ncbi.nlm.nih.gov/pubmed/36457601
http://dx.doi.org/10.7759/cureus.30812

Ejemplares similares